Dr. Yehia Hashad

Dr. Yehia Hashad

Executive Vice President of Research & Development and Chief Medical OfficeratBausch & Lomb· In proxies 2022–2025

Pay in FY2025-38% from the year before

Dr. Yehia Hashad was paid $2.8M in FY2025 (Dec), down 38%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Bausch & Lomb proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Bausch & LombPublic company · 4 yr
    • Executive Vice President of Research & Development and Chief Medical Officer2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?